| | | Indel (missense variant) | Autoimmune lymphoproliferative syndrome type 4 +12 more | |
| | HRAS, LRRC56 (R164P +1 more) | Single nucleotide variant (missense variant +1 more) | Costello syndrome +5 more | |
| | HRAS, LRRC56 (T31P +1 more) | Single nucleotide variant (missense variant) | Cardiovascular phenotype +6 more | |
| | HRAS, LRRC56 (R161C +1 more) | Single nucleotide variant (missense variant +1 more) | not provided +6 more | |
| | | Single nucleotide variant (intron variant) | Autoimmune lymphoproliferative syndrome type 4 +12 more | GConflicting classifications of pathogenicity |
| | | Deletion (3 prime UTR variant +1 more) | RASopathy +14 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Malignant tumor of urinary bladder +6 more | |
| | | Single nucleotide variant (intron variant) | Lung cancer +12 more | |
| | | Single nucleotide variant (missense variant) | Linear nevus sebaceous syndrome +8 more | |
| | | Single nucleotide variant (intron variant) | RASopathy | |
| | HRAS, LRRC56 (L133H +1 more) | Single nucleotide variant (missense variant) | Cardiovascular phenotype +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Malignant tumor of urinary bladder +6 more | |
| | | Single nucleotide variant (intron variant) | not provided +13 more | |
| | | Single nucleotide variant (missense variant) | Linear nevus sebaceous syndrome | |
| | | Single nucleotide variant (missense variant) | Noonan syndrome 3 +15 more | |
| | HRAS, LRRC56 (R169Q +1 more) | Single nucleotide variant (missense variant +1 more) | Large congenital melanocytic nevus +8 more | |
| | | Single nucleotide variant (missense variant +1 more) | Large congenital melanocytic nevus +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | Cardiofaciocutaneous syndrome 2 +12 more | |
| | HRAS, LRRC56 (R169W +1 more) | Single nucleotide variant (missense variant +1 more) | Costello syndrome +7 more | |
| | | Single nucleotide variant (intron variant) | RASopathy +12 more | |
| | | Single nucleotide variant (missense variant +1 more) | Noonan syndrome and Noonan-related syndrome +1 more | |
| | | Single nucleotide variant (synonymous variant) | RASopathy | |
| | | Single nucleotide variant (synonymous variant +1 more) | Noonan syndrome and Noonan-related syndrome +8 more | |
| | | Single nucleotide variant (synonymous variant) | RASopathy | |
| | | Single nucleotide variant (missense variant) | Noonan syndrome | |
| | HRAS, LRRC56 (P174S +1 more) | Single nucleotide variant (missense variant +1 more) | RASopathy | |
| | HRAS, LRRC56 (K170* +1 more) | Single nucleotide variant (nonsense +1 more) | Costello syndrome | |
| | | Single nucleotide variant (synonymous variant +1 more) | RASopathy | |
| | | Single nucleotide variant (missense variant +1 more) | Noonan syndrome and Noonan-related syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Large congenital melanocytic nevus +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +6 more | |
| | | Single nucleotide variant (missense variant +1 more) | Noonan syndrome | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +10 more | |
| | | Single nucleotide variant (missense variant +1 more) | Malignant tumor of urinary bladder +8 more | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Noonan syndrome | |
| | | Single nucleotide variant (missense variant) | Juvenile myelomonocytic leukemia +5 more | |
| | | Single nucleotide variant (missense variant) | Cardiovascular phenotype +6 more | GPathogenic/Likely pathogenic |